NOUVEAUX ANTICORPS ANTI-PCSK9

• 收藏
• 分享

专利权人:

Wuxi Biologics Ireland Limited.

发明人:

LIU, Jieying,LI, Jing

申请号：

EP17852309

公开号：

EP3515950A4

申请日:

2017.09.12

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The present disclosure provides monoclonal antibodies against Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9), which can block the binding of PCSK9 to LDL receptor, and therefore lower the level LDL-C. The antibodies of disclosure provide very potent agents for the treatment of multiple CVDs.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/